<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092017000400230</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Efecto de la aspirina en la mortalidad del síndrome de distrés respiratorio agudo en pacientes internados en la Unidad de Cuidados Intensivos del Hospital Juárez de México]]></article-title>
<article-title xml:lang="en"><![CDATA[Effect of aspirin on the mortality of acute respiratory distress syndrome in patients admitted to the Intensive Care Unit of the Juarez hospital in Mexico]]></article-title>
<article-title xml:lang="pt"><![CDATA[Efeito da aspirina sobre a mortalidade na síndrome da angústia respiratória aguda em pacientes internados na unidade de terapia intensiva do Hospital Juárez de México]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vásquez Cuellar]]></surname>
<given-names><![CDATA[Adolfo Israel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Nieto]]></surname>
<given-names><![CDATA[Orlando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pozos Cortez]]></surname>
<given-names><![CDATA[Pamela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hinojosa Espinoza]]></surname>
<given-names><![CDATA[Ivonne]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zamora Gómez]]></surname>
<given-names><![CDATA[Sergio Edgar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Juárez de México  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2017</year>
</pub-date>
<volume>31</volume>
<numero>4</numero>
<fpage>230</fpage>
<lpage>237</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092017000400230&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092017000400230&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092017000400230&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Objetivo:  Determinar el efecto en la morbimortalidad del uso de la aspirina después de 28 días en pacientes con SDRA.  Material y métodos:  Se realizó un ensayo clínico experimental, prospectivo aleatorizado simple durante el periodo comprendido del 01 diciembre de 2015 al 30 de junio de 2016 en la UCI del Hospital Juárez de México. Se incluyeron todos los pacientes que ingresaron a la UCI durante el periodo de estudio con diagnóstico de SDRA y se dividieron en dos grupos de manera aleatoria. Al grupo A se le administraron 100 mg de aspirina además del tratamiento estándar para SDRA y el grupo B sólo recibió tratamiento médico estándar para SDRA. Se cuantificaron los cambios en los valores de PaO2/FiO2, los valores de DA-aO2 y de Cstat, días de ventilación mecánica, así como la asociación de los valores del score APACHE II y su relación con la morbimortalidad en ambos grupos. Se utilizó la prueba estadística T de Student para variables independientes.  Resultados:  La mortalidad en el grupo A fue de 60% versus 80% en el grupo B. No se evidenció diferencia entre ambos grupos en la PaO2/FiO2 (p = 0.097). En el grupo A se observó una media de días de ventilación mecánica de 15.8 días versus 16.8 en el grupo B (p = 0.860, IC 95%), respecto a los días de estancia en la UCI y estancia intrahospitalaria no hubo diferencia estadísticamente significativa.  Conclusiones:  El uso de aspirina en pacientes con SDRA establecido, independientemente de su gravedad, no disminuye la mortalidad, ni acorta los días de estancia en la UCI o de estancia hospitalaria, como tampoco reduce los días de ventilación mecánica, ni mejora la PaO2/FiO2, la DAaO2 o la Cstat.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Objective:  To determine the effect on morbidity and mortality at 28 days with the use of aspirin in patients with ARDS.  Material and methods:  An experimental, prospective randomized clinical trial simply was conducted during the period from December 1, 2015 to June 30, 2016 in the ICU of Hospital Juarez of Mexico. all patients admitted to the ICU during the study period with a diagnosis of ARDS and were divided into two groups randomly included. Group A received 100 mg of aspirin in addition to standard treatment for ARDS, group B received only standard medical treatment for ARDS. changes in the values of PaO2/FiO2, the values of the DA-aO2 and CESTAT, days of mechanical ventilation, as well as the association of the values of APACHE II score and its relationship with morbidity and mortality in both groups were quantified. Statistical T Student test was used for independent variables.  Results:  Mortality in group A was 60% versus 80% in group B. No difference was observed in both groups in the PaO2/FiO2 (p = 0.097). In group A, an average of days of mechanical ventilation of 15.8 days versus 16.8 in group B (p = 0.860, 95%) compared to the days of stay in the ICU and hospital stay was found no statistically significant difference was observed.  Conclusions:  The use of aspirin in patients with ARDS established, regardless of severity; it does not decrease mortality, days of stay in the ICU or Hospital, nor diminish the days of mechanical ventilation, or improve PaO2/FiO2, the DAaO2, and CESTAT.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Objetivo:  Para determinar o efeito sobre a morbimortalidade aos 28 dias com o uso da aspirina em pacientes com SARA.  Material e métodos:  Realizou-se um ensaio clínico experimental, prospectivo randomizado simples, durante o período compreendido de 01 de dezembro de 2015 a 30 de junho de 2016 na UTI do Hospital Juárez do México. Foram incluídos todos os pacientes admitidos na UTI durante o período do estudo com um diagnóstico de SARA e foram divididos em dois grupos aleatoriamente. O Grupo A recebeu 100 mg de aspirina ademais do tratamento padrão para a SARA, o grupo B recebeu apenas o tratamento médico padrão para a SARA. Foram quantificados as alterações nos valores da PaO2/FiO2, valores DA-aO2 e Cestat, dias de ventilação mecânica, associação dos valores da pontuação APACHE II e a sua relação com a morbimortalidade em ambos os grupos. Se utilizou a prova estatística teste T Student para variáveis independentes.  Resultados:  A mortalidade no grupo A foi de 60% versus 80% no grupo B. Não se evidenciou diferença em ambos grupos na PaO2/FiO2 (p = 0.097). No Grupo A encontramos uma média de dias de ventilação mecânica de 15.8 dias versus 16.8 no grupo B (p = 0.860, IC 95%), com respeito aos dias de permanência na UTI e estadia hospitalar não observamos nenhuma diferença estatisticamente significativa.  Conclusões:  O uso da aspirina em pacientes com SARA estabelecido, independentemente da gravidade, não diminui a mortalidade, os dias de estadia na UTI e a estância hospitalar, assim como não diminui os dias de ventilação mecânica e não melhora a PaO2/FiO2, a DAaO2, e a Cestat.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[SDRA]]></kwd>
<kwd lng="es"><![CDATA[PaO2/FiO2]]></kwd>
<kwd lng="es"><![CDATA[Cestat]]></kwd>
<kwd lng="es"><![CDATA[DAaO2]]></kwd>
<kwd lng="es"><![CDATA[VM]]></kwd>
<kwd lng="es"><![CDATA[UCI]]></kwd>
<kwd lng="en"><![CDATA[ARDS]]></kwd>
<kwd lng="en"><![CDATA[PaO2 /FiO2]]></kwd>
<kwd lng="en"><![CDATA[Cestat]]></kwd>
<kwd lng="en"><![CDATA[DAaO2,VM]]></kwd>
<kwd lng="en"><![CDATA[ICU]]></kwd>
<kwd lng="pt"><![CDATA[SDRA]]></kwd>
<kwd lng="pt"><![CDATA[PaO2 /FiO2]]></kwd>
<kwd lng="pt"><![CDATA[Cestat]]></kwd>
<kwd lng="pt"><![CDATA[DAaO2]]></kwd>
<kwd lng="pt"><![CDATA[VM]]></kwd>
<kwd lng="pt"><![CDATA[UTI]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bernard]]></surname>
<given-names><![CDATA[GR]]></given-names>
</name>
<name>
<surname><![CDATA[Artigas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Brigham]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Carlet]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Falke]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hudson]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The American European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>1994</year>
<volume>149</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>818-24</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Phua]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
<name>
<surname><![CDATA[Ferguson]]></surname>
<given-names><![CDATA[ND]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute respiratory distress syndrome 40 years later time to revisit its definition]]></article-title>
<source><![CDATA[Crit Care Med]]></source>
<year>2008</year>
<volume>36</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>2912-21</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ranieri]]></surname>
<given-names><![CDATA[VM]]></given-names>
</name>
<name>
<surname><![CDATA[Rubenfeld]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[BT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The ARDS Definition Task Force Acute respiratory distress syndrome. The Berlin Definition]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2012</year>
<volume>307</volume>
<numero>23</numero>
<issue>23</issue>
<page-range>2526-33</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Villar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Blanco]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Añón]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Santos-Bouza]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Blanch]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ambrós]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The ALIEN study incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>2011</year>
<volume>37</volume>
<page-range>1932-41</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tomashefski]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pulmonary pathology of acute respiratory distress syndrome]]></article-title>
<source><![CDATA[Clin Chest Med]]></source>
<year>2000</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>425-66</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peñuelas]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Aramburu]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Frutos-Vivar]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Esteban]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pathology of acute lung injury and acute respiratory distress syndrome: a clinical-pathological correlation]]></article-title>
<source><![CDATA[Clin Chest Med]]></source>
<year>2006</year>
<volume>27</volume>
<page-range>571-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boyle]]></surname>
<given-names><![CDATA[Andrew J]]></given-names>
</name>
<name>
<surname><![CDATA[Di Gangi]]></surname>
<given-names><![CDATA[Stefania]]></given-names>
</name>
<name>
<surname><![CDATA[Hamid]]></surname>
<given-names><![CDATA[Umar I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2015</year>
<volume>19</volume>
<page-range>109</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eickmeier]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Seki]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Haworth]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Hilberath]]></surname>
<given-names><![CDATA[JN]]></given-names>
</name>
<name>
<surname><![CDATA[Gao]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Uddin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury]]></article-title>
<source><![CDATA[Mucosal Immunol]]></source>
<year>2013</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>256-66</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boyle]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mac Sweeney]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[McAuley]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacological treatments in ARDS a state-of-the-art update]]></article-title>
<source><![CDATA[BMC Med]]></source>
<year>2013</year>
<volume>11</volume>
<page-range>166</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Imran]]></surname>
<given-names><![CDATA[HU]]></given-names>
</name>
<name>
<surname><![CDATA[Conlon]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Spence]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Krasnodembskaya]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kissenpfennig]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[McAuley]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[O'Kane]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspirin reduces neutrophilic pulmonary inflammation in a human model of acute respiratory distress syndrome induced by inhaled lipopolysaccharide]]></article-title>
<source><![CDATA[Intensive Care Medicine Experimental]]></source>
<year>2014</year>
<volume>2</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>80</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zarbock]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Polanowska-Grabowska]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
<name>
<surname><![CDATA[Ley]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Platelet-neutrophilinteractions linking hemostasis and inflammation]]></article-title>
<source><![CDATA[Blood Rev]]></source>
<year>2007</year>
<volume>21</volume>
<page-range>99-111</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Lea]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Oldfield]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Docampo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes]]></article-title>
<source><![CDATA[J Biol Chem]]></source>
<year>2004</year>
<volume>279</volume>
<page-range>44250-7</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Morrell]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Platelets as initiators and mediators of inflammation at the vessel wall]]></article-title>
<source><![CDATA[Thromb Res]]></source>
<year>2011</year>
<volume>127</volume>
<page-range>387-90</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yaguchi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lobo]]></surname>
<given-names><![CDATA[FL]]></given-names>
</name>
<name>
<surname><![CDATA[Vincent]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Pradier]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Platelet function in sepsis]]></article-title>
<source><![CDATA[J Thromb Haemost]]></source>
<year>2004</year>
<volume>2</volume>
<page-range>2096-102</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gros]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ollivier]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ho-Tin-Noé]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Platelets in inflammation regulation of leukocyte activities and vascular repair]]></article-title>
<source><![CDATA[Front Immunol]]></source>
<year>2015</year>
<volume>5</volume>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
<name>
<surname><![CDATA[Weyrich]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Platelets as central mediators of systemic inflammatory responses]]></article-title>
<source><![CDATA[Thromb Res]]></source>
<year>2011</year>
<volume>127</volume>
<page-range>391-4</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McDonald]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Urrutia]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Yipp]]></surname>
<given-names><![CDATA[BG]]></given-names>
</name>
<name>
<surname><![CDATA[Jenne]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
<name>
<surname><![CDATA[Kubes]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis]]></article-title>
<source><![CDATA[Cell Host Microbe]]></source>
<year>2012</year>
<volume>12</volume>
<page-range>324-33</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zawrotniak]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rapala-Kozik]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neutrophil extracellular traps (NETs)-formation and implications]]></article-title>
<source><![CDATA[Acta Biochim Pol]]></source>
<year>2013</year>
<volume>60</volume>
<page-range>277-84</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fuchs]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Brill]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Duerschmied]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Schatzberg]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Monestier]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Extracellular DNA traps promote thrombosis]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA]]></source>
<year>2010</year>
<volume>107</volume>
<page-range>15880-5</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Asaduzzaman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lavasani]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rahman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rahman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Braun]]></surname>
<given-names><![CDATA[OO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Platelets support pulmonary recruitment of neutrophils in abdominal sepsis]]></article-title>
<source><![CDATA[Crit Care Med]]></source>
<year>2009</year>
<volume>37</volume>
<page-range>1389-96</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hidalgo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Jang]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Peired]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chiang]]></surname>
<given-names><![CDATA[EY]]></given-names>
</name>
<name>
<surname><![CDATA[Frenette]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury]]></article-title>
<source><![CDATA[Nat Med]]></source>
<year>2009</year>
<volume>15</volume>
<page-range>384-91</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goff]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Corbin]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Theiss]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Frierson]]></surname>
<given-names><![CDATA[HF]]></given-names>
</name>
<name>
<surname><![CDATA[Cephas]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Tribble]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Postinjury thromboxane receptor blockade ameliorates acute lung injury]]></article-title>
<source><![CDATA[Ann Thorac Surg]]></source>
<year>1997</year>
<volume>64</volume>
<page-range>826-9</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grommes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Alard]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Drechsler]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wantha]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Morgelin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kuebler]]></surname>
<given-names><![CDATA[WM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2012</year>
<volume>185</volume>
<page-range>628-36</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eisen]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manifold beneficial effects of acetyl salicylic acid and nonsteroidal anti-inflammatory drugs on sepsis]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>2012</year>
<volume>38</volume>
<page-range>1249-57</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gawaz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dickfeld]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Bogner]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fateh-Moghadam]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Neumann]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Platelet function in septic multiple organ dysfunction syndrome]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>1997</year>
<volume>23</volume>
<page-range>379-85</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Idell]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Maunder]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Fein]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Switalska]]></surname>
<given-names><![CDATA[HI]]></given-names>
</name>
<name>
<surname><![CDATA[Tuszynski]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
<name>
<surname><![CDATA[McLarty]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Platelet-specific alpha-granule proteins and thrombospondin in bronchoalveolar lavage in the adult respiratory distress syndrome]]></article-title>
<source><![CDATA[Chest]]></source>
<year>1989</year>
<volume>96</volume>
<page-range>1125-32</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ortiz-Muñoz]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Mallavia]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Bins]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Headley]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Krummel]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Looney]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice]]></article-title>
<source><![CDATA[Blood]]></source>
<year>2014</year>
<volume>23</volume>
<page-range>2625-34</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mandal]]></surname>
<given-names><![CDATA[RV]]></given-names>
</name>
<name>
<surname><![CDATA[Mark]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kradin]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Megakaryocytes and platelet homeostasis in diffuse alveolar damage]]></article-title>
<source><![CDATA[Exp Mol Pathol]]></source>
<year>2007</year>
<volume>83</volume>
<page-range>327-31</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Floyd]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
<name>
<surname><![CDATA[Ferro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mechanisms of aspirin resistance]]></article-title>
<source><![CDATA[Pharmacol Ther]]></source>
<year>2014</year>
<volume>141</volume>
<page-range>69-78</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weber]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Erl]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Pietsch]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Weber]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspirin inhibits nuclear factor B mobilization and monocyte adhesion in stimulated human endothelial cells]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>1995</year>
<volume>91</volume>
<page-range>1914-7</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Taubert]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Berkels]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Grosser]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Schröder]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Gründemann]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Schömig]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspirin induces nitric oxide release from vascular endothelium a novel mechanism of action]]></article-title>
<source><![CDATA[Br J Pharmacol]]></source>
<year>2004</year>
<volume>143</volume>
<page-range>159-65</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
